Is NERV A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives...
Minerva Neurosciences Inc. (NERV)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 912,000 | $2,663 | +83% | 0.06% |
| 2. | Millennium Management Israel Englander | 571,601 | $1,669 | +41% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 539,600 | $1,576 | -6% | 0% |
| 4. | Renaissance Technologies Jim Simons | 439,100 | $1,282 | -37% | 0% |
| 5. | Cormorant Asset Management Bihua Chen | 200,000 | $584 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.97 | 7,000 | Director | 20,333 | 2020-09-10 | Filing | |
| $5.50 | 3,500 | Director | 26,111 | 2019-06-27 | Filing | |
| $5.37 | 10,000 | Director | 13,333 | 2019-06-26 | Filing | |
| $5.25 | 1,000 | Director | 1,000 | 2019-06-26 | Filing | |
| $5.60 | 10,000 | Director | 10,000 | 2019-06-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.64 | 3,228 | Officer | 31,747 | 2020-12-16 | Filing | |
| $2.64 | 6,190 | Officer | 211,354 | 2020-12-16 | Filing | |
| $2.64 | 1,300 | Officer, Director | 66,490 | 2020-12-16 | Filing | |
| $2.64 | 1,845 | Officer | 10,039 | 2020-12-16 | Filing | |
| $15.00 | 8,339 | Officer | 6,884 | 2020-05-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,610,200 | $28,062 | 0.05% | |
| 2. | 4,597 | $13,423 | 0% | |
| 3. | 4,422,673 | $12,914 | 0% | |
| 4. | 2,333,369 | $6,812 | 0% | |
| 5. | 1,741,615 | $5,086 | 0.01% |
News See All
Hedge Fund Sentiment Is Stagnant On Minerva Neurosciences, Inc (NERV)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful...
Hedge Funds Are Buying Minerva Neurosciences, Inc (NERV)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Minerva Neurosciences, Inc (NERV): Are Hedge Funds Right About This Stock?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Is Minerva Neurosciences, Inc (NERV) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and...
Hedge Funds Aren’t Crazy About Minerva Neurosciences Inc (NERV) Anymore
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Baker Bros. Opened Positions In These 5 Healthcare Stocks
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000. The fund invests only in the healthcare sector, with a large chunk of its portfolio being represented by biotechnology stocks and its...
Here’s Why We’re Excited About The Upcoming Minerva Neurosciences Inc (NERV) Data
Minerva Neurosciences Inc (NASDAQ:NERV) just served up an update as to the progress of its two lead programs, and the company has remained relatively flat on the insight. There’s an important element...
Kingsway Financial Services Inc. (USA) (KFS) and Two Pharmaceutical Companies Register Insider Buying
The U.S. Securities and Exchange Commission prohibits executives and Board members from trading their company’s stock if they possess material non-public information about their company. Nonetheless...
Minerva Neurosciences Inc (NERV) Shares Skyrocket Following Successful Schizophrenia Drug Trial
Shares of Minerva Neurosciences Inc (NASDAQ:NERV) have surged by more than 235% today after the company announced positive results from the Phase IIb trial of its antidepressant drug candidate MIN-101...
Billionaire Hedge Funds
